Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03949140 · ClinicalTrials.gov registry record · NA
Laser Hair Removal for Treatment of Pilonidal Disease
A NA study of Pilonidal Disease, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT03949140: Completed NA study of Pilonidal Disease, sponsored by University of Wisconsin, Madison.
NCT03949140 is a NA study of Pilonidal Disease that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 22 participants, below the 144-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03949140, a NA study of Pilonidal Disease, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is a pilot study to determine if symptomatic pilonidal disease can be primarily managed with laser hair removal vs surgery.
Primary Outcome
Disease free rate among those subjects who only required laser therapy. Disease-free remission will be assessed at 12 and 24 months.
Conditions Studied
Interventions
- PROCEDURE Laser hair removal
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2019-02-18 |
| Est. Completion | 2021-10-30 |
| Phase | NA |
What the finished NCT03949140 record still lists
NCT03949140 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 144-participant average among 5 other Pilonidal Disease trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Pilonidal Disease appearing as the primary indexed condition, and to 1 intervention - of which Laser hair removal is the first listed.
NCT03949140 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT03949140 about?
NCT03949140 is a clinical study titled "Laser Hair Removal for Treatment of Pilonidal Disease". This project is a pilot study to determine if symptomatic pilonidal disease can be primarily managed with laser hair removal vs surgery.
What is the current status of trial NCT03949140?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2019-02-18. Estimated completion is 2021-10-30.
What conditions does trial NCT03949140 study?
This clinical trial studies the following conditions: Pilonidal Disease.
What interventions are being tested in trial NCT03949140?
The interventions under investigation include: Laser hair removal (PROCEDURE).
Who is sponsoring clinical trial NCT03949140?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03949140 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pilonidal Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Trial Assessing the Effectiveness of Laser Hair Depilation on Pilonidal Disease Recurrence in Patients With Darker Skin Color
RECRUITING · NA
-
Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous Flap-Based Closure of Pilonidal Disease
RECRUITING · NA
-
Comparing Operative vs Non Operative Treatment for Pilonidal Disease
RECRUITING · NA
-
Topical Anti-Androgens in Pilonidal Sinus Disease
RECRUITING · Phase 2
-
MIPE for Pilonidal Disease
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI